Diabetes Ketoacidosis - CTV3 (DKA - unspecific)
Metadata
- Coding system
- Pseudo BNF
- Coding system release
- unknown
- Author
- Brian MacKenna
- Codelist ID
- user/brian-mackenna/diabetes-ketoacidosis-ctv3-dka-unspecific
- Version ID
- 10edca56
- Number of codes included
- 1
About
No metadata has been provided for this codelist.
Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.
We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.
| code | term |
|---|---|
| 0208020Y0 | Rivaroxaban |
This page shows the search terms that were used to build the codelist. Concepts that match the search terms, but which were excluded, are in faint grey.
rivaroxaban
Included 1 out of 13 matching concepts.
Show matching concepts
-
Rivaroxaban (
0208020Y0AA) -
Rivaroxaban (
0208020Y0) -
Rivaroxaban 10mg tablets (
0208020Y0AAAAAA) -
Rivaroxaban 15mg tablets (
0208020Y0AAABAB) -
Rivaroxaban 15mg tablets and Rivaroxaban 20mg tablets (
0208020Y0AAAEAE) -
Rivaroxaban 2.5mg tablets (
0208020Y0AAADAD) -
Rivaroxaban 20mg tablets (
0208020Y0AAACAC) -
Xarelto (
0208020Y0BB) -
Xarelto 10mg tablets (
0208020Y0BBAAAA) -
Xarelto 15mg / 20mg treatment initiation pack (
0208020Y0BBAEAE) -
Xarelto 15mg tablets (
0208020Y0BBABAB) -
Xarelto 2.5mg tablets (
0208020Y0BBADAD) -
Xarelto 20mg tablets (
0208020Y0BBACAC)